Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis

被引:27
作者
Lee, Sang Hoon [1 ]
Yeo, Yoomi [2 ]
Kim, Tae-Hyung [2 ]
Lee, Hong Lyeol [3 ]
Lee, Jin Hwa [4 ]
Park, Yong Bum [5 ]
Park, Jong Sun [6 ]
Kim, Yee Hyung [7 ]
Song, Jin Woo [8 ]
Jhun, Byung Woo [9 ]
Kim, Hyun Jung [10 ]
Park, Jinkyeong [9 ]
Uh, Soo-Taek [11 ]
Kim, Young Whan [12 ]
Kim, Dong Soon [8 ]
Park, Moo Suk [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Inst Chest Dis, Dept Internal Med,Coll Med,Div Pulmonol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Hanyang Univ, Guri Hosp, Div Pulm & Crit Care Med, Coll Med, Guri, South Korea
[3] Inha Univ, Inha Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, Incheon, South Korea
[4] Ewha Womans Univ, Dept Internal Med, Div Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[5] Hallym Univ, Coll Med, Dept Internal Med, Kangdong Sacred Heart Hosp,Lung Res Inst, Seoul, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, Seongnam, South Korea
[7] Kyung Hee Univ Hosp Gangdong, Div Pulm & Crit Care Med, Seoul, South Korea
[8] Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[9] Sungkyunkwan Univ, Samsung Med Ctr, Div Pulm & Crit Care Med, Sch Med, Seoul, South Korea
[10] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea
[11] Soonchunhyang Univ, Dept Internal Med, Seoul Hosp, Seoul, South Korea
[12] Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea
关键词
Idiopathic Pulmonary Fibrosis; Diagnosis; Disease Management; Korea; ENDOPLASMIC-RETICULUM STRESS; ACID GASTROESOPHAGEAL-REFLUX; FORCED VITAL CAPACITY; ACUTE EXACERBATION; PREDICTING SURVIVAL; EPITHELIAL-CELLS; GENE-EXPRESSION; HIGH PREVALENCE; SCORING SYSTEM; CT FINDINGS;
D O I
10.4046/trd.2018.0091
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
引用
收藏
页码:102 / 117
页数:16
相关论文
共 115 条
  • [1] CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis
    Akira, M
    Hamada, H
    Sakatani, M
    Kobayashi, C
    Nishioka, M
    Yamamoto, S
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (01) : 79 - 83
  • [2] Body mass index and mortality in patients with idiopathic pulmonary fibrosis
    Alakhras, Mazen
    Decker, Paul A.
    Nadrous, Hassan F.
    Collazo-Clavell, Maria
    Ryu, Jay H.
    [J]. CHEST, 2007, 131 (05) : 1448 - 1453
  • [3] Short telomeres are a risk factor for idiopathic pulmonary fibrosis
    Alder, Jonathan K.
    Chen, Julian J. -L.
    Lancaster, Lisa
    Danoff, Sonye
    Su, Shu-Chih
    Cogan, Joy D.
    Vulto, Irma
    Xie, Mingyi
    Qi, Xiaodong
    Tuder, Rubin M.
    Phillips, John A., III
    Lansdorp, Peter M.
    Loyd, James E.
    Armanios, Mary Y.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13051 - 13056
  • [4] American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277
  • [5] [Anonymous], 2013, NICE CLIN GUID
  • [6] Telomerase mutations in families with idiopathic pulmonary fibrosis
    Armanios, Mary Y.
    Chen, Julian J. -L.
    Cogan, Joy D.
    Alder, Jonathan K.
    Ingersoll, Roxann G.
    Markin, Cheryl
    Lawson, William E.
    Xie, Mingyi
    Vulto, Irma
    Phillips, John A., III
    Lansdorp, Peter M.
    Greider, Carol W.
    Loyd, James E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) : 1317 - 1326
  • [7] Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
    Baumgartner, KB
    Samet, JM
    Stidley, CA
    Colby, TV
    Waldron, JA
    Coultas, DB
    Davis, GS
    Garcia, JGN
    Hunninghake, GW
    Kallay, MC
    King, TE
    Krowka, MJ
    Rennard, SI
    Ryu, JH
    Sherman, CB
    Smith, LJ
    Toews, G
    Winterbauer, RH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) : 242 - 248
  • [8] Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis
    Bellaye, Pierre-Simon
    Kolb, Martin
    [J]. BMC MEDICINE, 2015, 13
  • [9] Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
    Bjoraker, JA
    Ryu, JH
    Edwin, MK
    Myers, JL
    Tazelaar, HD
    Schroeder, DR
    Offord, KP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) : 199 - 203
  • [10] Dynamic Patient Counseling A Novel Concept in Idiopathic Pulmonary Fibrosis
    Brown, A. Whitney
    Shlobin, Oksana A.
    Weir, Nargues
    Albano, Maria C.
    Ahmad, Shahzad
    Smith, Mary
    Leslie, Kevin
    Nathan, Steven D.
    [J]. CHEST, 2012, 142 (04) : 1005 - 1010